- Home
- Publications
- Publication Search
- Publication Details
Title
PD-L1 Expression in Patients with Idiopathic Pulmonary Fibrosis
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 23, Pages 5562
Publisher
MDPI AG
Online
2021-12-01
DOI
10.3390/jcm10235562
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition
- (2021) Samy Hakroush et al. Frontiers in Immunology
- Immune checkpoint inhibitor-related pneumonitis in lung cancer: real-world incidence, risk factors, and management practices across six health care centers in North Carolina
- (2021) William T. Atchley et al. CHEST
- Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis
- (2021) Atsushi Hata et al. INTERNATIONAL JOURNAL OF CANCER
- Integration of cryobiopsies for interstitial lung disease diagnosis is a valid and safe diagnostic strategy—experiences based on 250 biopsy procedures
- (2021) Sissel Kronborg-White et al. Journal of Thoracic Disease
- Disease pathology in fibrotic interstitial lung disease: is it all about usual interstitial pneumonia?
- (2021) Elisabetta A Renzoni et al. LANCET
- The Efficacy and Safety of PD-1/PD-L1 Inhibitors in Combination with Conventional Therapies for Advanced Solid Tumors: A Meta-Analysis
- (2020) Run-Cong Nie et al. Biomed Research International
- Le nivolumab peut-il être utilisé dans les fibroses pulmonaires idiopathiques ?
- (2019) B. Duchemann et al. REVUE DES MALADIES RESPIRATOIRES
- Epithelial–Mesenchymal Transition in the Pathogenesis of Idiopathic Pulmonary Fibrosis
- (2019) Francesco Salton et al. Medicina-Lithuania
- Resequencing Study Confirms Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis
- (2019) Camille Moore et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Report Standardization in Transbronchial Lung Cryobiopsy
- (2019) Claudia Ravaglia et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Common Pathogenetic Mechanisms Between IPF and Lung Cancer
- (2019) A. Tzouvelekis et al. CHEST
- Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
- (2019) Oliver Distler et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer
- (2019) Trine Vilsbøll Larsen et al. Cancer Communications
- Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial
- (2019) Daichi Fujimoto et al. LUNG CANCER
- Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
- (2019) Kevin R. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2019) Toby M Maher et al. Lancet Respiratory Medicine
- Management of pulmonary toxicity associated with immune checkpoint inhibitors
- (2019) Myriam Delaunay et al. European Respiratory Review
- PD-1/PD-L1 Pathway Mediates the Alleviation of Pulmonary Fibrosis by Human Mesenchymal Stem Cells in Humanized Mice
- (2018) Ke Ni et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma
- (2018) A. Asgarova et al. OncoImmunology
- Lung cancer in idiopathic pulmonary fibrosis: A systematic review and meta-analysis
- (2018) AliReza JafariNezhad et al. PLoS One
- PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production
- (2018) Lindsay J. Celada et al. Science Translational Medicine
- Durable response to nivolumab in a lung adenocarcinoma patient with idiopathic pulmonary fibrosis
- (2018) Maako Ide et al. Thoracic Cancer
- Membrane PD-L1 expression and soluble PD-L1 plasma levels in idiopathic pulmonary fibrosis—a pilot study
- (2018) Dragana Jovanovic et al. Journal of Thoracic Disease
- Official ERS technical standards: Global Lung Function Initiative reference values for the carbon monoxide transfer factor for Caucasians
- (2017) Sanja Stanojevic et al. EUROPEAN RESPIRATORY JOURNAL
- Increased frequency of bronchiolar histotypes in lung carcinomas associated with idiopathic pulmonary fibrosis
- (2017) Anna Caliò et al. HISTOPATHOLOGY
- Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial
- (2017) Jürgen Behr et al. BMC Pulmonary Medicine
- Fibroblastic foci, covered with alveolar epithelia exhibiting epithelial–mesenchymal transition, destroy alveolar septa by disrupting blood flow in idiopathic pulmonary fibrosis
- (2016) Miki Yamaguchi et al. LABORATORY INVESTIGATION
- Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer
- (2013) M. Sznol et al. CLINICAL CANCER RESEARCH
- Heterogeneous distribution of mechanical stress in human lung: A mathematical approach to evaluate abnormal remodeling in IPF
- (2013) A. Carloni et al. JOURNAL OF THEORETICAL BIOLOGY
- Premature lung aging and cellular senescence in the pathogenesis of idiopathic pulmonary fibrosis and COPD/emphysema
- (2013) Marco Chilosi et al. Translational Research
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- Exposures and Idiopathic Lung Disease
- (2009) Varsha Taskar et al. SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More